[Non-A, non-B hepatitis in patients with chronic hemodialysis].
A prospective study was conducted of the incidence and course of acute viral hepatitis in 69 chronic hemodialysis patients. During a mean observation period of 15.4 months, 5.6 cases/100 patients/year of non-A, non-B hepatitis and 1.1 cases/100 patients/year of hepatitis B virus infection occurred. 19 out of 38 patients with serologic evidence of immunity against hepatitis B virus infection developed the antibody to hepatitis B surface antigen after active immunization. All cases of non-A, non-B hepatitis had an asymptomatic course, but there was a tendency to chronicity. The overall impact of non-A, non-B hepatitis in patients on chronic hemodialysis is discussed.
D000328:Adult; D000368:Aged; D005260:Female; D006509:Hepatitis B / Q000453:epidemiology / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000032:analysis; D006511:Hepatitis B Antigens / Q000032:analysis; D006526:Hepatitis C / Q000453:epidemiology / Q000209:etiology*; D006525:Hepatitis, Viral, Human / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects*; D013557:Switzerland; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use
D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D014761:Viral Hepatitis Vaccines
Non-A-non-B-Hepatitis bei chronisch hämodialysierten Patienten.